Skip to content

Dr. Pieter Lambrecht

Active Private limited companyfounded 2016active for 10 yearsDriftweg 127, 8450 BredeneKBO/BCE: BE 0662.856.824

Lifetime

9 annual accounts with figures on one time axis
peak of €804,400 in 2024
€769,183▼ 4.4%
peak of €600,116 in 2024
€583,879▼ 2.7%
peak of €334,793 in 2018
€18,600▼ 18.0%
€607,881▼ 2.3%
Board1 name since 2016
1 director
Documentsfilings and deeds
05-01-2026115 days before the deadline
2025micro format
Dividend €587,963Equity from €22,684 to €18,600Cash from €48,635 to €32,975

Key points

from the 2025 annual accounts

Equity

€18,600 from €334,793 in 2018

Equity fell by 94% in 7 years.

Debts

€607,881 97% of the balance sheet

Position in the sector

3.0%

Lower solvency than 92% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 538 companies had the same profile as Dr. Pieter Lambrecht has now. Each dot stands for 2 companies, two years later.

95.7%
were still trading
3.5%
stopped another way
0.7%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 538 companies, not a prediction for Dr. Pieter Lambrecht. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 186 sharesdeed of 26-09-2016
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0662856824
Registered office moved to Bredene The registered office moved to Driftweg 127, 8450 Bredene · resigns as manager · reappointed as director · General meeting of 27-08-2021 · Gazette deed
Incorporation Founding capital of €18,600, 186 shares, €12,400 paid up · Founded by (mandate holder) · appointed as manager · published on 26-09-2016 · Gazette deed
2 establishments registered Ostend
All 15 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Pieter Lambrecht Bredene €626,481 €769,183 3.0% -
DR. DE SPIEGELEIRE - DR. STEEN Staden €701,756 €757,274 86.7% -
Dr. D. Cottens, cardioloog – Dr. C. Lambrecht, dermatoloog Hasselt €707,852 €798,786 20.9% -
Dr. O. BROUCKAERT Ypres €599,183 €686,343 11.8% -
Dr. Steven Heireman Kortrijk €524,577 €666,156 3.5% -
Bruspor Bruges €777,194 €646,787 84.8% -
Dr. Esther Passchyn Jabbeke €595,850 €596,984 65.7% -

These companies have the same main activity as Dr. Pieter Lambrecht: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €525,000 and €777,000, founded between 2015 and 2018.

Official details

Source: KBO
Status
Active since 22-09-2016Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment units
2.257.694.1038400 Ostend, since 22-09-2016
2.257.694.2028400 Ostend, since 22-09-2016
Financial year end
30 September
Peppol
Reachable since 02-04-2024
Company details

Annual accounts to 30-09-2025

≈ €1.2mestimated
€626,481▼ 2.9%
Filing
Filed on 05-01-2026, 115 days before the end of the filing period
Financials

Insights on Dr. Pieter Lambrecht

Dr. Pieter Lambrecht files the micro format. That format states no turnover. The gross margin rose from €136,702 in 2017 to €769,183 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Pieter Lambrecht

What is the company number of Dr. Pieter Lambrecht?
The company number of Dr. Pieter Lambrecht is 0662.856.824. The VAT number is the same number with BE in front: BE 0662.856.824.
Where is Dr. Pieter Lambrecht based?
The registered office is at Driftweg 127, 8450 Bredene.Company details
What does Dr. Pieter Lambrecht do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Pieter Lambrecht?
Dr. Pieter Lambrecht is a private limited company (BV).
When was Dr. Pieter Lambrecht founded?
Dr. Pieter Lambrecht was founded on 22-09-2016.
Is Dr. Pieter Lambrecht still active?
Yes, Dr. Pieter Lambrecht is an active enterprise in the KBO register.
What is the turnover of Dr. Pieter Lambrecht?
The turnover in financial year 2025 is about €1.2m. This figure is estimated from the gross margin of €769,183 and 31 comparable companies (NACE 86220). It probably lies between €1.0m and €1.6m.Financials
Is Dr. Pieter Lambrecht profitable?
In financial year 2025, Dr. Pieter Lambrecht made a profit of €583,879.
Where can I find the annual accounts of Dr. Pieter Lambrecht?
Dr. Pieter Lambrecht filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Pieter Lambrecht due?
Dr. Pieter Lambrecht must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.